Subscribe To
ANGO / AngioDynamics' (ANGO) New FDA Recognition to Boost Treatment
ANGO News
By Zacks Investment Research
October 6, 2023
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP. more_horizontal
By Zacks Investment Research
October 5, 2023
AngioDynamics (ANGO) Q1 Earnings and Revenues Top Estimates
AngioDynamics (ANGO) registers strong revenue growth in the Med Tech business in first-quarter fiscal 2024. more_horizontal
By The Motley Fool
October 4, 2023
Why Angiodynamics Stock Sank Today
The medical device and technology specialist unveiled its latest set of quarterly results. Its bottom line was in the red and only marginally beat est more_horizontal
By Zacks Investment Research
October 4, 2023
AngioDynamics (ANGO) Reports Q1 Loss, Tops Revenue Estimates
AngioDynamics (ANGO) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to loss o more_horizontal
By Seeking Alpha
September 17, 2023
AngioDynamics: Enormous Effort Required In Fiscal '24 To Reverse The Equity Picture
AngioDynamics, Inc. posted mixed results in its FY'23 reports, with strong growth in its Med Tech division. The company's focus going forward will be more_horizontal
By Zacks Investment Research
August 17, 2023
AngioDynamics (ANGO) Flat As Market Sinks: What You Should Know
AngioDynamics (ANGO) closed at $8.58 in the latest trading session, marking no change from the prior day. more_horizontal
By Zacks Investment Research
August 16, 2023
AngioDynamics' (ANGO) New FDA Recognition to Boost Treatment
The FDA's grant of the Breakthrough Device designation for AngioDynamics' (ANGO) AngioVac is likely to remove thrombus and embolic material and minimi more_horizontal
By Zacks Investment Research
July 12, 2023
AngioDynamics (ANGO) Lags Q4 Earnings Estimates
AngioDynamics (ANGO) came out with quarterly earnings of $0.02 per share, missing the Zacks Consensus Estimate of $0.03 per share. This compares to ea more_horizontal